IPG-1094
N/A
Report date: 2026/05/02 20:00:18
NMEFirst In Class
Base Information
Drug NameIPG-1094
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNanjing Immunophage Biotech Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesNanjing Immunophage Biotech Co Ltd
Inactive CompaniesN/A
Active Indications +[8]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A